Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 15;256(1-2):38-42.
doi: 10.1016/j.jneuroim.2013.01.002. Epub 2013 Feb 4.

Systemic immune system alterations in early stages of Alzheimer's disease

Rongzhen Zhang  1 , Robert G Miller, Catherine Madison, Xia Jin, Ronald Honrada, Will Harris, Jonathan Katz, Dallas A Forshew, Michael S McGrath
Affiliations

Systemic immune system alterations in early stages of Alzheimer's disease

Rongzhen Zhang et al. J Neuroimmunol. .

Abstract

Immune activation and inflammation play significant roles in the pathogenesis of Alzheimer's disease (AD). To test whether AD patients showed systemic manifestations of inflammation, blood from 41 patients with early stages of AD and 31 aged-match elderly controls were evaluated. Cellular markers for monocyte/macrophage (MO) activation and CD8 T lymphocyte were increased in early AD patients. Expression of monocyte CCR2, the receptor for monocyte chemoattractant protein-1 (MCP-1), was decreased; however, plasma MCP-1 levels were significantly increased and were related to the degree of MO activation in AD. These findings suggest that AD pathogenesis may be influenced by systemic immunologic dysfunction and provides potential immunologic targets for therapeutic intervention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship of plasma MCP-1 levels to macrophage activation/differentiation defined by CD14 co-expression of CD16 in elderly controls and patients with early stages of AD. Positive correlation of plasma MCP-1 levels with degree of CD16 expression on CD14+ monocyte in early AD (r = 0.5006, p = 0.0127, n = 24).
Figure 2
Figure 2
Relationship between monocyte CD16 expression and CD14+ monocyte granularity in elderly controls and patients with early stages of AD. Positive correlation of monocyte CD16 expression with CD14+ monocyte granularity in early AD (r = 0.7042, p < 0.0001, n = 41).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abeles RD, McPhail MJ, Sowter D, Antoniades CG, Vergis N, Vijay GK, Xystrakis E, Khamri W, Shawcross DL, Ma Y, Wendon JA, Vergani D. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi)/CD16(neg) monocytes: Expansion of CD14(hi)/CD16(pos) and contraction of CD14(lo)/CD16(pos) monocytes in acute liver failure. Cytometry Part A: the journal of the International Society for Analytical Cytology. 2012;81:823–834. - PubMed
    1. Ancuta P, Moses A, Gabuzda D. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology. 2004;209:11–20. - PubMed
    1. Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. Journal of leukocyte biology. 2006;80:1156–1164. - PubMed
    1. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, Espevik T, Ziegler-Heitbrock L. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002;168:3536–3542. - PubMed
    1. Britschgi M, Wyss-Coray T. Systemic and acquired immune responses in Alzheimer’s disease. International review of neurobiology. 2007;82:205–233. - PubMed

Publication types